AstraZeneca Galida NDA Delayed Until 2007 Due To PPAR Safety Concerns
AstraZeneca will delay an NDA filing for its dual PPAR Galida (tesaglitazar) until 2007 in order to gather two years of long-term follow-up data
AstraZeneca will delay an NDA filing for its dual PPAR Galida (tesaglitazar) until 2007 in order to gather two years of long-term follow-up data